AHNAK2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-57661
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the middle region of human AHNAK2. Peptide Sequence KEEGELIGPVGTGLDSRVMVTSAARTELILPEQDRKADDESKGSGLGPNEG. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for AHNAK2 Antibody
Western Blot: AHNAK2 Antibody [NBP1-57661]
Western Blot: AHNAK2 Antibody [NBP1-57661] - Reccomended Titration: 0.2 - 1 ug/ml ELISA Titer: 1:312500 Positive Control: HepG2 cell lysateApplications for AHNAK2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Application Notes
A 85kDa band is detected and identified as Isoform 2. The full-length protein has not yet been detected in WB.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: AHNAK2
Alternate Names
AHNAK nucleoprotein 2, C14orf78, chromosome 14 open reading frame 78, KIAA2019, protein AHNAK2
Gene Symbol
AHNAK2
Additional AHNAK2 Products
Product Documents for AHNAK2 Antibody
Product Specific Notices for AHNAK2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...